Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chollet

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 17, 2011
Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution studyE Monrigal, J Dauplat, P Gimbergues, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancersC Theodore, L Geoffrois, J B Vermorken, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Follow-up results from a randomized trial for T3 and T4 breast cancer patients: previous BCG immunotherapy improves response to chemotherapy in the relapse patientB Serrou, H Sancho-Garnier, P Cappelaere, et al.
British Journal of Cancer|October 2, 2003
Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?P Chollet, S Amat, E Belembaogo, et al.
Bulletin Du Cancer|January 1, 1997
[First-line chemotherapy in operable breast neoplasms: results of 3 protocols]H Cure, S Charrier, J P Ferrière, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancerD Khayat, P Chollet, E C Antoine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancerH Curé, V Chevalier, A Adenis, et al.
British Journal of Cancer|April 16, 2002
Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancerP Chollet, S Amat, H Cure, et al.
Bone Marrow Transplantation|February 1, 1997
rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trialM Legros, J Fleury, J O Bay, et al.
Investigational New Drugs|May 4, 2004
Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumorsM J A de Jonge, J P Droz, L Paz-Ares, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 17, 2011
Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution studyE Monrigal, J Dauplat, P Gimbergues, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancersC Theodore, L Geoffrois, J B Vermorken, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Follow-up results from a randomized trial for T3 and T4 breast cancer patients: previous BCG immunotherapy improves response to chemotherapy in the relapse patientB Serrou, H Sancho-Garnier, P Cappelaere, et al.
British Journal of Cancer|October 2, 2003
Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?P Chollet, S Amat, E Belembaogo, et al.
Bulletin Du Cancer|January 1, 1997
[First-line chemotherapy in operable breast neoplasms: results of 3 protocols]H Cure, S Charrier, J P Ferrière, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancerD Khayat, P Chollet, E C Antoine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancerH Curé, V Chevalier, A Adenis, et al.
British Journal of Cancer|April 16, 2002
Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancerP Chollet, S Amat, H Cure, et al.
Bone Marrow Transplantation|February 1, 1997
rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trialM Legros, J Fleury, J O Bay, et al.
Investigational New Drugs|May 4, 2004
Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumorsM J A de Jonge, J P Droz, L Paz-Ares, et al.
Pageof 14